CRL vs MET · rev $2.00B vs P/E 13, rev $38.23B
Charles River Laboratories (CRL) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
CRL currently screens at market cap $7.78B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the CRL and MET stock pages for the full models.
Not investment advice.